Stocks Explorer
Stocks
Sectors
Search
Supernus Pharmaceuticals Inc(S49) News
Profile
Chart
News
Analysis
S49 price today
by TradingView
Date
Title
Jan 7
Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 9.4% CAGR over the last five years
‹ Prev
Page
of 1
Next ›